Literature DB >> 22381845

Endoscopic third ventriculostomy and posterior fossa tumors.

Federico Di Rocco1, Carlos Eduardo Jucá, Michel Zerah, Christian Sainte-Rose.   

Abstract

BACKGROUND: The management of hydrocephalus associated with a posterior fossa tumor is debated. Some authors emphasize the advantages of an immediate tumor removal that may normalize the cerebrospinal fluid (CSF) dynamics. However, in clinical practice, the mere excision of the lesion has been demonstrated to be accompanied by a persisting hydrocephalus in about one third of the cases. Preoperative endoscopic third ventriculostomy (ETV) offers several advantages. It may control the intracranial pressure (ICP), avoid the necessity of an emergency procedure, allow appropriate scheduling of the operation for tumor removal, and eliminate the risks related to the presence of an external drainage. The procedure also reduces the incidence of postoperative hydrocephalus. A final advantage, more difficult to weight, but obvious to the neurosurgeon, is the possibility to remove the lesion with a relaxed brain and normal ICP. In the postoperative phase, ETV can be used in case of persisting hydrocephalus, both in patients who underwent only the excision of the tumor and in those whose preoperative ETV failed as a consequence of intraventricular bleeding with secondary closure of the stoma (redoETV). The main advantage of postoperative ETV is that the procedure is carried out only in case of persisting hydrocephalus; its use is consequently more selective than preoperative ETV. The disadvantage consists in the common use of an external CSF drainage in the first few postoperative days, which is necessary to control the pressure and for ruling out those cases that reach a spontaneous cure of the hydrocephalus.
METHODS: The authors review the criteria for patient selection and the results of ETV performed in case of hydrocephalus secondary to a posterior fossa tumor. RESULTS AND
CONCLUSIONS: Preoperative ETV constitutes an effective procedure for controlling the hydrocephalus associated with posterior fossa tumors. It might lower the rate of persistent postoperative hydrocephalus and result in a short hospital stay. Low rates of patients requiring an extrathecal-CSF shunt device are also reported by authors who utilize ETV postoperatively. As, however, the assessment of the persistent hydrocephalus in these children is based on prolonged ICP monitoring through an external CSF drainage, their results are weighted by a major risk of infective complications and longer hospital stay.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22381845     DOI: 10.1016/j.wneu.2012.02.018

Source DB:  PubMed          Journal:  World Neurosurg        ISSN: 1878-8750            Impact factor:   2.104


  14 in total

1.  Predictive factors associated with ventriculoperitoneal shunting after posterior fossa tumor surgery in children.

Authors:  Leonie Johanna Helmbold; Gertrud Kammler; Jan Regelsberger; Friederike Sophie Fritzsche; Pedram Emami; Ulrich Schüller; Kara Krajewski
Journal:  Childs Nerv Syst       Date:  2019-03-30       Impact factor: 1.475

2.  Medulloblastoma.

Authors:  Katja von Hoff; Stefan Rutkowski
Journal:  Curr Treat Options Neurol       Date:  2012-08       Impact factor: 3.598

3.  Provider views on perioperative steroid use for patients with newly diagnosed pediatric brain tumors.

Authors:  Fatema Malbari; Kristen A Staggers; Charles G Minard; Howard L Weiner; Murali M Chintagumpala; Adam S Levy
Journal:  J Neurooncol       Date:  2020-02-05       Impact factor: 4.130

4.  Evaluation of clinical characteristics as indicators for shunt procedure in patients with medulloblastoma: PS210.

Authors:  A Paunović; F Milisavljević; J Bošković
Journal:  Porto Biomed J       Date:  2017-09-01

5.  Management of hydrocephalus in pediatric metastatic tumors of the posterior fossa at presentation.

Authors:  Luc Le Fournier; Matthieu Delion; Maxime Esvan; Emilie De Carli; Céline Chappé; Philippe Mercier; Philippe Menei; Laurent Riffaud
Journal:  Childs Nerv Syst       Date:  2017-05-11       Impact factor: 1.475

Review 6.  Management of posterior fossa tumors and hydrocephalus in children: a review.

Authors:  Chih-Ta Lin; Jay K Riva-Cambrin
Journal:  Childs Nerv Syst       Date:  2015-09-09       Impact factor: 1.475

Review 7.  Treatment Strategies and Challenges to Avoid Cerebrospinal Fluid Shunting for Pediatric Hydrocephalus.

Authors:  Young-Soo Park
Journal:  Neurol Med Chir (Tokyo)       Date:  2022-08-27       Impact factor: 2.036

Review 8.  Endoscopic third ventriculostomy with/without choroid plexus cauterization for hydrocephalus due to hemorrhage, infection, Dandy-Walker malformation, and neural tube defect: a meta-analysis.

Authors:  Anthony Zandian; Matthew Haffner; James Johnson; Curtis J Rozzelle; R Shane Tubbs; Marios Loukas
Journal:  Childs Nerv Syst       Date:  2013-12-28       Impact factor: 1.475

9.  Treatment Outcome of Hydrocephalus Associated with Vestibular Schwannoma.

Authors:  Dong Won Shin; Sang Woo Song; SangJoon Chong; Young Hoon Kim; Young Hyun Cho; Seok Ho Hong; Jeong Hoon Kim
Journal:  J Clin Neurol       Date:  2021-07       Impact factor: 3.077

10.  Management of hydrocephalus in children with posterior fossa tumors.

Authors:  Sandi Lam; Gaddum D Reddy; Yimo Lin; Andrew Jea
Journal:  Surg Neurol Int       Date:  2015-07-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.